The Role of NLRP Gene Family (NLRP1~14) in Recurrent Miscarriage and Infertility
Dr. Pao-Lin Kuo (Department of Obstetrics and Gynecology)
1 other identifier
observational
143
1 country
1
Brief Summary
Development of mole was not associated with segregation of mutated NLRP7 allele in the haploid oocyte. We hypothesize NLRP7 is a maternal factor involved in regulating early embryo development or embryo-uterine interaction. In the proposed study, we seek to identify novel genetic variants and mutations of NLRP7 in women who experienced RM/HM. Genetic association study and haplotype analysis are performed to test assocation between NLRP7 gene and female reproductive performance. Immunohistochemical staining, RT-PCR, and Western blot analysis are used to investigate expression pattern of NLRP7 in endometrium and placenta. Two approaches are used to characterize functional significance of genetic variants/mutations. The first approach will be based on mutagenesis and the second approach will be based on induced pluripotent stem cells (iPSCs). Results obtained from the proposed study will provide novel insight into mechanism of embryo development and implantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2015
CompletedFirst Posted
Study publicly available on registry
October 28, 2019
CompletedOctober 4, 2022
October 1, 2019
3.9 years
April 7, 2014
October 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pregnancy outcome
Pregnancy and delivery of a normal baby is defined as normal outcome
1 month at the end of pregnancy
Secondary Outcomes (1)
spontaneous abortion
abortion before 12 weeks of gestation
Other Outcomes (1)
intrauterine fetal death
fetal death after 12 weeks of gestation
Eligibility Criteria
Assuming that there are 300 cases and 300 controls enrolled, the underlying disease model is recessive, the disease prevalence is approximately 3% and the disease allele frequency is about 5%, this study has more than 80% power for detecting the SNP with an allele frequency greater than 10% and an allelic odds ratio greater than 1.4. We assumed that the SNP is either the causal gene or in LD with the causal allele and power was calculated without multiple testing corrections.
You may qualify if:
- Recurrent abortions and infertility treatments but combined with repetitive (more than two consecutive) implantation failure couples, rather than general infertility couples.
You may not qualify if:
- Women who do not have recurrent miscarriage and infertility problems.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cheng-Kung University Hospital
Tainan, 70428, Taiwan
Biospecimen
DNA extracted from peripheral blood.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pao-Lin Kuo, MD
Department of Obstetrics and Gynecology, National Cheng Kung University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2014
First Posted
October 28, 2019
Study Start
August 1, 2011
Primary Completion
July 1, 2015
Study Completion
July 31, 2015
Last Updated
October 4, 2022
Record last verified: 2019-10